(Q45885668)

17 December 2017

title

PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses (English)

1 reference

17 December 2017

1 reference

P T Sobol

1

1 reference

17 December 2017

J L Hummel

series ordinal

2

1 reference

17 December 2017

R M Rodrigues

series ordinal

3

1 reference

17 December 2017

K L Mossman

series ordinal

4

1 reference

17 December 2017

publication date

28 May 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

1077-1087

1 reference

17 December 2017

Oncolytic viral therapies

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Getting oncolytic virus therapies off the ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Implications for RNase L in prostate cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

IRF family of transcription factors as regulators of host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

The role of PML in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Loss of the tumor suppressor PML in human cancers of multiple histologic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Review: properties and assembly mechanisms of ND10, PML bodies, or PODs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

The function of PML in p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Role of PML in cell growth and the retinoic acid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Role and fate of PML nuclear bodies in response to interferon and viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Herpes simplex virus ICP0 mutants are hypersensitive to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Oncolytic herpes simplex virus vector g47delta in combination with androgen ablation for the treatment of human prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

A role for cytoplasmic PML in cellular resistance to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Cytoplasmic PML function in TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

PML nuclear bodies and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.68

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2009.68

1 reference

17 December 2017

Dimensions Publication ID

1002905222

0 references

1 reference

17 December 2017